価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TLR9, Mouse-Mono(26C593.2)
データシート
NBP2-24729 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 mg ¥108,000
(未発注)
追加

在庫・価格 : 2025年04月29日 23時55分 現在

Anti-TLR9, Mouse-Mono(26C593.2)

  • 商品コード:NBP2-24729
  • メーカー:NOV
  • 包装:0.1mg
  • 価格: ¥108,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Cognasse F et al. Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6. Immunology 2008 Nov;125(3):430-7
Cognasse F et al
2008/01/01
PubMed
2 Dasgupta G et al. Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses. Invest. Ophthalmol. Vis. Sci. 2011 May;52(6):3321-33
Dasgupta G et al
2011/01/01
PubMed
3 Myles A et al. Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Rheumatology (Oxford) 2011 Mar;50(3):481-8
Myles A et al
2011/01/01
PubMed
4 O'Hara JR et al. Campylobacter jejuni Disrupts Protective Toll-Like Receptor 9 Signaling in Colonic Epithelial Cells and Increases the Severity of Dextran Sulfate Sodium-Induced Colitis in Mice. Infect. Immun. 2012 Apr;80(4):1563-71
O'Hara JR et al
2012/01/01
PubMed
5 Sethi RS et al. Immunolocalization of pulmonary intravascular macrophages, TLR4, TLR9 and IL-8 in normal and Pasteurella multocida-infected lungs of water buffalo (Bubalus bubalis). J. Comp. Pathol. ;144(2-3):135-44
Sethi RS et al
PubMed
6 Kim YI et al. Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula. J. Immunol. 2010 Mar;184(6):3145-56
Kim YI et al
2010/01/01
PubMed
7 Chentoufi AA et al. Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization. Clin. Vaccine Immunol. 2010 Mar;17(3):342-53
Chentoufi AA et al
2010/01/01
PubMed
8 Palladino MA et al. Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract. Biol. Reprod. 2007 Jun;76(6):958-64
Palladino MA et al
2007/01/01
PubMed
9 Belmont L et al. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer. Int. J. Cancer 2014 Feb;134(4):765-77
Belmont L et al
2014/01/01
PubMed
10 Ewaschuk JB et al. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect. Immun. 2007 May;75(5):2572-9
Ewaschuk JB et al
2007/01/01
PubMed
11 Zuo D et al. Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity. FASEB J. 2012 Apr;26(4):1493-505
Zuo D et al
2012/01/01
PubMed
12 Meneghin A et al. TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation. Histochem. Cell Biol. 2008 Nov;130(5):979-92
Meneghin A et al
2008/01/01
PubMed
13 Chauhan SK et al. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J. Clin. Immunol. 2013 Jul;33(5):954-64
Chauhan SK et al
2013/01/01
PubMed
14 Ju X et al. CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood 2008 Aug;112(4):1184-94
Ju X et al
2008/01/01
PubMed
15 Nakano S et al. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology (Oxford) 2008 Feb;47(2):145-9
Nakano S et al
2008/01/01
PubMed
16 Kindrachuk J et al. Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of Toll-like receptor 9. J. Biol. Chem. 2007 May;282(19):13944-53
Kindrachuk J et al
2007/01/01
PubMed
17 Figueiredo MM et al. Expression of Toll-like receptors 2 and 9 in cells of dog jejunum and colon naturally infected with Leishmania infantum. BMC Immunol. 2013;14(1):22
Figueiredo MM et al
2013/01/01
PubMed
18 Selleri S et al. Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS. Int. Immunol. 2008 Aug;20(8):961-70
Selleri S et al
2008/01/01
PubMed
19 Lee HK et al. Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation. J. Biol. Chem. 2004 Mar;279(11):10564-74
Lee HK et al
2004/01/01
PubMed
20 Booth JS et al. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides. J Innate Immun 2010;2(5):483-94
Booth JS et al
2010/01/01
PubMed
21 Srivastava MD et al. Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line. Leuk. Res. 2005 Jul;29(7):813-20
Srivastava MD et al
2005/01/01
PubMed
22 Karim R et al. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS ONE 2011;6(3):e17848
Karim R et al
2011/01/01
PubMed
23 Tran N et al. Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J. Clin. Endocrinol. Metab. 2007 Jul;92(7):2773-83
Tran N et al
2007/01/01
PubMed
24 Machida H et al. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol. Dial. Transplant. 2010 Aug;25(8):2530-537
Machida H et al
2010/01/01
PubMed
25 V辰is辰nen MR et al. Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer. Oncol Lett 2013 May;5(5):1659-1663
V辰is辰nen MR et al
2013/01/01
PubMed
26 Nakamura K et al. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. J. Immunol. 2008 Mar;180(6):4067-74
Nakamura K et al
2008/01/01
PubMed
27 Jukkola-Vuorinen A et al. Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer. J Innate Immun 2009;1(1):59-68
Jukkola-Vuorinen A et al
2009/01/01
PubMed
28 Wong CK et al. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am. J. Respir. Cell Mol. Biol. 2007 Jul;37(1):85-96
Wong CK et al
2007/01/01
PubMed
29 Souza-Fonseca-Guimaraes F et al. NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis. J. Immunol. 2012 Jun;188(12):5850-8
Souza-Fonseca-Guimaraes F et al
2012/01/01
PubMed
30 Mansson A et al. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir. Res. 2006;7:36
Mansson A et al
2006/01/01
PubMed
31 Gonzalez JM et al. Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state? Am. J. Obstet. Gynecol. 2007 Sep;197(3):296.e1-6
Gonzalez JM et al
2007/01/01
PubMed
32 Burgener IA et al. Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry. Vet. Immunol. Immunopathol. 2008 Jul;124(1-2):184-91
Burgener IA et al
2008/01/01
PubMed
33 Kauppila JH et al. Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS 2013 Jun;121(6):511-22
Kauppila JH et al
2013/01/01
PubMed
34 Lee J et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 2006 Dec;8(12):1327-36
Lee J et al
2006/01/01
PubMed
35 Palladino MA et al. Localization of Toll-like receptors on epididymal epithelial cells and spermatozoa. Am. J. Reprod. Immunol. 2008 Dec;60(6):541-55
Palladino MA et al
2008/01/01
PubMed
36 van Gent M et al. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J. Immunol. 2011 Feb;186(3):1694-702
van Gent M et al
2011/01/01
PubMed
37 Wu J et al. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 2010 Mar;129(3):363-74
Wu J et al
2010/01/01
PubMed
38 Abdi J et al. Characterization of the Toll-like receptor expression profile in human multiple myeloma cells. PLoS ONE 2013;8(4):e60671
Abdi J et al
2013/01/01
PubMed
39 Wang C et al. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients. BMC Cancer 2010;10:415
Wang C et al
2010/01/01
PubMed
40 Harman AN et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J. Immunol. 2013 Jan;190(1):66-79
Harman AN et al
2013/01/01
PubMed
41 Greene CM et al. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol. 2005 Feb;174(3):1638-46
Greene CM et al
2005/01/01
PubMed
42 Zhang YW et al. Molecular cloning and characterization of equine Toll-like receptor 9. Vet. Immunol. Immunopathol. 2008 Aug;124(3-4):209-19
Zhang YW et al
2008/01/01
PubMed
43 Silver AC et al. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity 2012 Feb;36(2):251-61
Silver AC et al
2012/01/01
PubMed
44 Keestra AM et al. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J. Immunol. 2010 Jul;185(1):460-7
Keestra AM et al
2010/01/01
PubMed
45 Zhou M et al. Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol. Immunother. 2009 Sep;58(9):1375-85
Zhou M et al
2009/01/01
PubMed
46 Sacre SM et al. Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J. Immunol. 2008 Dec;181(11):8002-9
Sacre SM et al
2008/01/01
PubMed
47 Schneberger D et al. Expression of toll-like receptor 9 in lungs of pigs, dogs and cattle. Int J Exp Pathol 2011 Feb;92(1):1-7
Schneberger D et al
2011/01/01
PubMed
48 Lee J et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 2006 Feb;103(6):1828-33
Lee J et al
2006/01/01
PubMed
49 Miller LS et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J. Immunol. 2005 May;174(10):6137-43
Miller LS et al
2005/01/01
PubMed
50 Pegu A et al. Human lymphatic endothelial cells express multiple functional TLRs. J. Immunol. 2008 Mar;180(5):3399-405
Pegu A et al
2008/01/01
PubMed
51 Cognasse F et al. Evidence of Toll-like receptor molecules on human platelets. Immunol. Cell Biol. 2005 Apr;83(2):196-8
Cognasse F et al
2005/01/01
PubMed
52 Schneberger D et al. Expression of Toll-like receptor 9 in mouse and human lungs. J. Anat. 2013 May;222(5):495-503
Schneberger D et al
2013/01/01
PubMed
53 Hu F et al. Spontaneous production of immunoglobulin M in human epithelial cancer cells. PLoS ONE 2012;7(12):e51423
Hu F et al
2012/01/01
PubMed
54 Siponen M et al. TLR4 and TLR9 are induced in oral lichen planus. J. Oral Pathol. Med. 2012 Nov;41(10):741-7
Siponen M et al
2012/01/01
PubMed
55 Meng Y et al. Expression of TLR9 within human glioblastoma. J. Neurooncol. 2008 May;88(1):19-25
Meng Y et al
2008/01/01
PubMed
56 Abel K et al. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey pl
Abel K et al
2005/01/01
PubMed
57 Hammadi A et al. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation. Nitric Oxide 2008 Sep;19(2):138-45
Hammadi A et al
2008/01/01
PubMed
58 Dhara A et al. Molecular characterization of coding sequences and analysis of Toll-like receptor 3 mRNA expression in water buffalo (Bubalus bubalis) and nilgai (Boselaphus tragocamelus). Immunogenetics 2007 Jan;59(1):69-76
Dhara A et al
2007/01/01
PubMed
59 Martin-Armas M et al. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J. Hepatol. 2006 May;44(5):939-46
Martin-Armas M et al
2006/01/01
PubMed
60 Gottenberg JE et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjテθ津つカgren's syndrome. Proc. Natl. Acad. Sci. U.S.A. 2006 Feb;103(8):2770-5
Gottenberg JE et al
2006/01/01
PubMed
61 Niessner A et al. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation 2006 Dec;114(23):2482-9
Niessner A et al
2006/01/01
PubMed
62 Cohen PA et al. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells. Blood 2008 Sep;112(5):1832-43
Cohen PA et al
2008/01/01
PubMed
63 Tabeta K et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 2006 Feb;7(2):156-64
Tabeta K et al
2006/01/01
PubMed
64 Donaghy H et al. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J. Virol. 2009 Feb;83(4):1952-61
Donaghy H et al
2009/01/01
PubMed
65 Panda A et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J. Immunol. 2010 Mar;184(5):2518-27
Panda A et al
2010/01/01
PubMed
66 Droemann D et al. Human lung cancer cells express functionally active Toll-like receptor 9. Respir. Res. 2005;6:1
Droemann D et al
2005/01/01
PubMed
67 Bharti D et al. The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics 2014 Dec;66(12):675-81
Bharti D et al
2014/01/01
Species: Human, Applications: FLOW PubMed
68 Sathe A et al. TLR9 and RIG-I signaling in human endocervical epithelial cells modulates inflammatory responses of macrophages and dendritic cells in vitro. PLoS ONE 2014;9(1):e83882
Sathe A et al
2014/01/01
Species: Human, Applications: WB, Flow-IC, ICC/IF PubMed
69 Kauppila JH et al. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue. J. Oral Pathol. Med. 2014 Oct;
Kauppila JH et al
2014/01/01
Species: Human, Applications: IHC-P, B/N PubMed
70 Korvala J et al. Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis. J. Oral Pathol. Med. 2014 Aug;43(7):530-7
Korvala J et al
2014/01/01
Species: Human, Applications: WB, IHC-P PubMed
71 Yu SL et al. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis. Lupus 2014 Nov;
Yu SL et al
2014/01/01
Species: Human, Applications: Func, In vitro PubMed
72 Ruan M et al. Activation of Toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma. PLoS ONE 2014;9(3):e92748
Ruan M et al
2014/01/01
Species: Human, Applications: WB PubMed
73 Zufferey A et al. Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules. J Proteomics 2014 Apr;101:130-40
Zufferey A et al
2014/01/01
Species: Human, Applications: ICC/IF PubMed
74 Tengroth L et al. Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells. PLoS ONE 2014;9(6):e98239
Tengroth L et al
2014/01/01
Species: Human, Applications: IHC-P, ICC/IF PubMed
75 Fehri E et al. Expression of Toll-like receptor 9 increases with progression of cervical neoplasia in Tunisian women--a comparative analysis of condyloma, cervical intraepithelial neoplasia and invasive carcinoma. Asian Pac. J. Cancer Prev. 2014;15(15):61
Fehri E et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
76 Hamidi S et al. TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts. Biochim. Biophys. Acta 2014 Apr;1841(4):484-94
Hamidi S et al
2014/01/01
Species: Human, Applications: ICC/IF PubMed
77 Ruan M et al. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma. Int. J. Oncol. 2014 Jun;44(6):2103-10
Ruan M et al
2014/01/01
Species: Human, Applications: WB PubMed
78 Veselits M et al. Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes. PLoS ONE 2014;9(3):e89792
Veselits M et al
2014/01/01
Species: Mouse, Applications: ICC/IF PubMed
79 Guerrier T et al. TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response. J. Autoimmun. 2014 Jun;51:23-9
Guerrier T et al
2014/01/01
Species: Human, Applications: In vitro PubMed
80 Chandel HS et al. Toll-like receptors and CD40 modulate each other's expression affecting Leishmania major infection. Clin. Exp. Immunol. 2014 May;176(2):283-90
Chandel HS et al
2014/01/01
Species: Mouse, Applications: WB PubMed
81 Huhta H et al. Toll-like receptor 9 expression in the natural history of Barrett mucosa. Virchows Arch. 2015 Jul;467(1):9-18
Huhta H et al
2015/01/01
Species: Human, Applications: IHC-P PubMed
82 Tengroth L et al. Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients. PLoS ONE 2014;9(8):e105618
Tengroth L et al
2014/01/01
Species: Human, Applications: FLOW PubMed
83 Karlsen M et al. Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome. PLoS ONE 2015;10(3):e0120383
Karlsen M et al
2015/01/01
Species: Human, Applications: FLOW PubMed
84 Luckhardt TR et al. TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis. Fibrogenesis Tissue Repair 2011;4:18
Luckhardt TR et al
2011/01/01
Applications: ICC/IF PubMed
85 Kundu SD et al. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 2008 Feb;68(2):223-9
Kundu SD et al
2008/01/01
PubMed
86 Kauppila JH et al. Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology 2011 Oct;59(4):643-9
Kauppila JH et al
2011/01/01
Species: Human PubMed
87 Saito K et al. Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE. Eur. J. Immunol. 2015 Jul;45(7):2028-41
Saito K et al
2015/01/01
Species: Human, Applications: WB, IP PubMed
88 V辰is辰nen MR et al. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors. Prostate 2010 Jun;70(8):817-24
V辰is辰nen MR et al
2010/01/01
Species: Human PubMed
89 Ronkainen H et al. Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma. J. Exp. Clin. Cancer Res. 2011;30:84
Ronkainen H et al
2011/01/01
Species: Human PubMed
90 Gantner F et al. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Eur. J. Immunol. 2003 Jun;33(6):1576-85
Gantner F et al
2003/01/01
PubMed
91 L坦pez MC et al. Naïve T cells, unconventional NK and NKT cells, and highly responsive monocyte-derived macrophages characterize human cord blood. Immunobiology 2014 Oct;219(10):756-65
L坦pez MC et al
2014/01/01
PubMed
92 Dillmann C et al. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells. J. Immunol. 2016 Feb;196(4):1579-90
Dillmann C et al
2016/01/01
PubMed
93 Zhong F et al. Deviation from major codons in the Toll-like receptor genes is associated with low Toll-like receptor expression. Immunology 2005 Jan;114(1):83-93
Zhong F et al
2005/01/01
PubMed
94 Jamin A et al. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome. Clin. Exp. Immunol. 2015 Dec;182(3):332-45
Jamin A et al
2015/01/01
PubMed
95 Wang H et al. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J. Immunol. 2006 Sep;177(5):2793-802
Wang H et al
2006/01/01
PubMed
96 Huggins J et al. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood 2007 Feb;109(4):1611-9
Huggins J et al
2007/01/01
PubMed
97 Meseure D et al. Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes. Cancer Microenviron 2016 Jul;
Meseure D et al
2016/01/01
PubMed
98 Acharya M et al. αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. Nat Commun 2016;7:10917
Acharya M et al
2016/01/01
PubMed
99 Duhamel M et al. The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways. Sci Rep 2016;6:19360
Duhamel M et al
2016/01/01
PubMed
100 Ilvesaro JM et al. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion. Mol. Cancer Res. 2008 Oct;6(10):1534-43
Ilvesaro JM et al
2008/01/01
PubMed
101 Schnerch J et al. Functional TLR9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis. Am. J. Respir. Cell Mol. Biol. 2016 Jul;
Schnerch J et al
2016/01/01
PubMed
102 Schneberger D et al. Expression of toll-like receptor 9 in horse lungs. Anat Rec (Hoboken) 2009 Jul;292(7):1068-77
Schneberger D et al
2009/01/01
PubMed
103 Mishima Y et al. Decreased Frequency of Intestinal Regulatory CD5+ B Cells in Colonic Inflammation. PLoS ONE 2016;11(1):e0146191
Mishima Y et al
2016/01/01
PubMed
104 Baumann CL et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J. Exp. Med. 2010 Nov;207(12):2689-701
Baumann CL et al
2010/01/01
PubMed
105 Siponen M et al. Cathepsin K expression is increased in oral lichen planus. J. Oral Pathol. Med. 2016 May;
Siponen M et al
2016/01/01
PubMed
106 Lundeen JS et al. Direct measurement of the quantum wavefunction. Nature 2011 Jun;474(7350):188-91
Lundeen JS et al
2011/01/01
PubMed
107 Moreira ML et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet. Parasitol. 2016 Apr;220:33-45
Moreira ML et al
2016/01/01
Species: Canine, Applications: FLOW PubMed
108 Heftrig D et al. Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients. Mediators Inflamm. 2017;2017:2608349
Heftrig D et al
2017/01/01
Species: Human, Applications: Flow PubMed
109 Damiano V et al. Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors. Clin. Cancer Res. 2006 Jan;12(2):577-83
Damiano V et al
2006/01/01
PubMed
110 Evangelista MG et al. Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. Autoimmunity 2016 Jun;49(4):258-67
Evangelista MG et al
2016/01/01
Species: Mouse, Applications: FLOW PubMed
111 Yang X et al. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J. Am. Coll. Cardiol. 2009 Feb;53(6):491-500
Yang X et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
112 Zambirinis CP et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J. Exp. Med. 2015 Nov;212(12):2077-94
Zambirinis CP et al
2015/01/01
Species: Mouse, Applications: Flow PubMed
113 Larsson O et al. Substance P represents a novel first-line defense mechanism in the nose. J. Allergy Clin. Immunol. 2018 Jan;141(1):128-136.e3
Larsson O et al
2018/01/01
Species: Mouse, Applications: Flow, ICC/IF, IHC PubMed
114 Huhta H et al. The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer. J. Histochem. Cytochem. 2016 08;64(8):470-82
Huhta H et al
2016/01/01
Species: Human, Applications: IHC-P PubMed
115 Lepp辰nen J et al. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients. Virchows Arch. 2017 Apr;470(4):401-410
Lepp辰nen J et al
2017/01/01
Species: Human, Applications: IHC PubMed
116 Yang J et al. Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome. Transpl. Immunol. 2018 06;48:39-46
Yang J et al
2018/01/01
Species: Human, Applications: PubMed
117 Mu L et al. Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression. World Neurosurg 2017 Jan;97:279-283
Mu L et al
2017/01/01
Species: Human, Applications: IHC PubMed
118 Jeon YK et al. Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination. Oncotarget 2016 Jul;7(27):41811-41824
Jeon YK et al
2016/01/01
Species: Human, Applications: DB PubMed
119 Chandler MR et al. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans. PLoS ONE 2017;12(9):e0183832
Chandler MR et al
2017/01/01
Species: Human, Applications: PubMed
120 Burgue単o JF et al. TLR2 and TLR9 modulate enteric nervous system inflammatory responses to lipopolysaccharide. J Neuroinflammation 2016 08;13(1):187
Burgue単o JF et al
2016/01/01
Species: Rat, Applications: ICC/IF PubMed
121 Helminen O et al. Localization of nucleic acid-sensing toll-like receptors in human and mouse pancreas. APMIS 2017 Feb;125(2):85-92
Helminen O et al
2017/01/01
Species: Human, Applications: IHC PubMed
122 Sun Y et al. High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway. Exp. Cell Res. 2017 10;359(2):312-318
Sun Y et al
2017/01/01
WB PubMed
123 Lim JS et al. The role of TLR9 in stress-dependent autophagy formation. Biochem. Biophys. Res. Commun. 2016 Dec;481(3-4):219-226
Lim JS et al
2016/01/01
Species: Human, Applications: PubMed
124 Takahara M et al. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy. Cell Immunol 2019 07;341:103925
Takahara M et al
2019/01/01
PubMed
125 Natarajan S et al. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468. Immunopharmacol Immunotoxicol 2020 Oct;42(
Natarajan S et al
2020/01/01
PubMed
126 Zhou B et al. Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma. Theranostics 2020;10(14):6530-6543
Zhou B et al
2020/01/01
PubMed
127 Du XK et al. Necroptosis in pulmonary macrophages mediates lipopolysaccharide-induced lung inflammatory injury by activating ZBP-1. Int Immunopharmacol 2019 Dec;77:105944
Du XK et al
2019/01/01
PubMed
128 Korimov叩 A et al. <i>N</i>-Formylated Peptide Induces Increased Expression of Both Formyl Peptide Receptor 2 (Fpr2) and Toll-Like Receptor 9 (TLR9) in Schwannoma Cells-An In Vitro Model for Early Inflammatory Profiling of Schwann Cells. Cells 2020 12;9(12
Korimov叩 A et al
2020/01/01
PubMed
129 Nie H et al. Bushen recipe and its disassembled prescriptions inhibit inflammation of liver injury associated with Concanavalin A through Toll&#x2011;like receptor 3/9 signaling pathway. Mol Med Rep 2018 Aug;18(2):1682-1691
Nie H et al
2018/01/01
PubMed
130 Wang CY et al. TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity. Biology (Basel) 2020 Oct;9(11)
Wang CY et al
2020/01/01
PubMed
131 Richard Albert J et al. Maternal DNMT3A-dependent de novo methylation of the paternal genome inhibits gene expression in the early embryo. Nat Commun 2020 10;11(1):5417
Richard Albert J et al
2020/01/01
PubMed
132 Niemczyk G et al. Expression of Toll-Like Receptors in the Animal Model of Bladder Outlet Obstruction. Biomed Res Int 2020;2020:6632359
Niemczyk G et al
2020/01/01
PubMed
133 Kuramoto K et al. The autophagy protein Becn1 improves insulin sensitivity by promoting adiponectin secretion via exocyst binding. Cell Rep 2021 May;35(8):109184
Kuramoto K et al
2021/01/01
PubMed
134 Li FJ et al. Citrullinated vimentin mediates development and progression of lung fibrosis. Sci Transl Med 2021 03;13(585)
Li FJ et al
2021/01/01
PubMed
135 Ishizu T et al. Head and neck squamous cell carcinoma cell lines have an immunomodulatory effect on macrophages independent of hypoxia and toll-like receptor 9. BMC Cancer 2021 Sep;21(1):990
Ishizu T et al
2021/01/01
Species: Human, Applications: WB PubMed
136 Branchi V et al. A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer. Diagnostics (Basel) 2021 Sep;11(9)
Branchi V et al
2021/01/01
Species: Human, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Cognasse F et al. Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6. Immunology 2008 Nov;125(3):430-7
    Cognasse F et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Dasgupta G et al. Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses. Invest. Ophthalmol. Vis. Sci. 2011 May;52(6):3321-33
    Dasgupta G et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Myles A et al. Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Rheumatology (Oxford) 2011 Mar;50(3):481-8
    Myles A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    O&#39;Hara JR et al. Campylobacter jejuni Disrupts Protective Toll-Like Receptor 9 Signaling in Colonic Epithelial Cells and Increases the Severity of Dextran Sulfate Sodium-Induced Colitis in Mice. Infect. Immun. 2012 Apr;80(4):1563-71
    O&#39;Hara JR et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Sethi RS et al. Immunolocalization of pulmonary intravascular macrophages, TLR4, TLR9 and IL-8 in normal and Pasteurella multocida-infected lungs of water buffalo (Bubalus bubalis). J. Comp. Pathol. ;144(2-3):135-44
    Sethi RS et al
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Kim YI et al. Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula. J. Immunol. 2010 Mar;184(6):3145-56
    Kim YI et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Chentoufi AA et al. Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization. Clin. Vaccine Immunol. 2010 Mar;17(3):342-53
    Chentoufi AA et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Palladino MA et al. Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract. Biol. Reprod. 2007 Jun;76(6):958-64
    Palladino MA et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Belmont L et al. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer. Int. J. Cancer 2014 Feb;134(4):765-77
    Belmont L et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Ewaschuk JB et al. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect. Immun. 2007 May;75(5):2572-9
    Ewaschuk JB et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Zuo D et al. Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity. FASEB J. 2012 Apr;26(4):1493-505
    Zuo D et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Meneghin A et al. TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation. Histochem. Cell Biol. 2008 Nov;130(5):979-92
    Meneghin A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Chauhan SK et al. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J. Clin. Immunol. 2013 Jul;33(5):954-64
    Chauhan SK et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Ju X et al. CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood 2008 Aug;112(4):1184-94
    Ju X et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Nakano S et al. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology (Oxford) 2008 Feb;47(2):145-9
    Nakano S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Kindrachuk J et al. Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of Toll-like receptor 9. J. Biol. Chem. 2007 May;282(19):13944-53
    Kindrachuk J et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Figueiredo MM et al. Expression of Toll-like receptors 2 and 9 in cells of dog jejunum and colon naturally infected with Leishmania infantum. BMC Immunol. 2013;14(1):22
    Figueiredo MM et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Selleri S et al. Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS. Int. Immunol. 2008 Aug;20(8):961-70
    Selleri S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lee HK et al. Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation. J. Biol. Chem. 2004 Mar;279(11):10564-74
    Lee HK et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Booth JS et al. TLR9 signaling failure renders Peyer&#39;s patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides. J Innate Immun 2010;2(5):483-94
    Booth JS et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Srivastava MD et al. Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line. Leuk. Res. 2005 Jul;29(7):813-20
    Srivastava MD et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Karim R et al. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS ONE 2011;6(3):e17848
    Karim R et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Tran N et al. Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J. Clin. Endocrinol. Metab. 2007 Jul;92(7):2773-83
    Tran N et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Machida H et al. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol. Dial. Transplant. 2010 Aug;25(8):2530-537
    Machida H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    V辰is辰nen MR et al. Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer. Oncol Lett 2013 May;5(5):1659-1663
    V辰is辰nen MR et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Nakamura K et al. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. J. Immunol. 2008 Mar;180(6):4067-74
    Nakamura K et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Jukkola-Vuorinen A et al. Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer. J Innate Immun 2009;1(1):59-68
    Jukkola-Vuorinen A et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Wong CK et al. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am. J. Respir. Cell Mol. Biol. 2007 Jul;37(1):85-96
    Wong CK et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Souza-Fonseca-Guimaraes F et al. NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis. J. Immunol. 2012 Jun;188(12):5850-8
    Souza-Fonseca-Guimaraes F et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Mansson A et al. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir. Res. 2006;7:36
    Mansson A et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Gonzalez JM et al. Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state? Am. J. Obstet. Gynecol. 2007 Sep;197(3):296.e1-6
    Gonzalez JM et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Burgener IA et al. Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry. Vet. Immunol. Immunopathol. 2008 Jul;124(1-2):184-91
    Burgener IA et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Kauppila JH et al. Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS 2013 Jun;121(6):511-22
    Kauppila JH et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Lee J et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol. 2006 Dec;8(12):1327-36
    Lee J et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Palladino MA et al. Localization of Toll-like receptors on epididymal epithelial cells and spermatozoa. Am. J. Reprod. Immunol. 2008 Dec;60(6):541-55
    Palladino MA et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    van Gent M et al. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J. Immunol. 2011 Feb;186(3):1694-702
    van Gent M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Wu J et al. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 2010 Mar;129(3):363-74
    Wu J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Abdi J et al. Characterization of the Toll-like receptor expression profile in human multiple myeloma cells. PLoS ONE 2013;8(4):e60671
    Abdi J et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Wang C et al. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients. BMC Cancer 2010;10:415
    Wang C et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Harman AN et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J. Immunol. 2013 Jan;190(1):66-79
    Harman AN et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Greene CM et al. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol. 2005 Feb;174(3):1638-46
    Greene CM et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Zhang YW et al. Molecular cloning and characterization of equine Toll-like receptor 9. Vet. Immunol. Immunopathol. 2008 Aug;124(3-4):209-19
    Zhang YW et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Silver AC et al. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity 2012 Feb;36(2):251-61
    Silver AC et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Keestra AM et al. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J. Immunol. 2010 Jul;185(1):460-7
    Keestra AM et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Zhou M et al. Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol. Immunother. 2009 Sep;58(9):1375-85
    Zhou M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Sacre SM et al. Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J. Immunol. 2008 Dec;181(11):8002-9
    Sacre SM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Schneberger D et al. Expression of toll-like receptor 9 in lungs of pigs, dogs and cattle. Int J Exp Pathol 2011 Feb;92(1):1-7
    Schneberger D et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Lee J et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 2006 Feb;103(6):1828-33
    Lee J et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Miller LS et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J. Immunol. 2005 May;174(10):6137-43
    Miller LS et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Pegu A et al. Human lymphatic endothelial cells express multiple functional TLRs. J. Immunol. 2008 Mar;180(5):3399-405
    Pegu A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Cognasse F et al. Evidence of Toll-like receptor molecules on human platelets. Immunol. Cell Biol. 2005 Apr;83(2):196-8
    Cognasse F et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Schneberger D et al. Expression of Toll-like receptor 9 in mouse and human lungs. J. Anat. 2013 May;222(5):495-503
    Schneberger D et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Hu F et al. Spontaneous production of immunoglobulin M in human epithelial cancer cells. PLoS ONE 2012;7(12):e51423
    Hu F et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Siponen M et al. TLR4 and TLR9 are induced in oral lichen planus. J. Oral Pathol. Med. 2012 Nov;41(10):741-7
    Siponen M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Meng Y et al. Expression of TLR9 within human glioblastoma. J. Neurooncol. 2008 May;88(1):19-25
    Meng Y et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Abel K et al. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey pl
    Abel K et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Hammadi A et al. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation. Nitric Oxide 2008 Sep;19(2):138-45
    Hammadi A et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Dhara A et al. Molecular characterization of coding sequences and analysis of Toll-like receptor 3 mRNA expression in water buffalo (Bubalus bubalis) and nilgai (Boselaphus tragocamelus). Immunogenetics 2007 Jan;59(1):69-76
    Dhara A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Martin-Armas M et al. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J. Hepatol. 2006 May;44(5):939-46
    Martin-Armas M et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Gottenberg JE et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjテθ津つカgren&#39;s syndrome. Proc. Natl. Acad. Sci. U.S.A. 2006 Feb;103(8):2770-5
    Gottenberg JE et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Niessner A et al. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation 2006 Dec;114(23):2482-9
    Niessner A et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Cohen PA et al. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells. Blood 2008 Sep;112(5):1832-43
    Cohen PA et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Tabeta K et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 2006 Feb;7(2):156-64
    Tabeta K et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Donaghy H et al. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J. Virol. 2009 Feb;83(4):1952-61
    Donaghy H et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Panda A et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J. Immunol. 2010 Mar;184(5):2518-27
    Panda A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Droemann D et al. Human lung cancer cells express functionally active Toll-like receptor 9. Respir. Res. 2005;6:1
    Droemann D et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Bharti D et al. The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics 2014 Dec;66(12):675-81
    Bharti D et al
    2014/01/01
  • 備考:
    Species: Human, Applications: FLOW
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Sathe A et al. TLR9 and RIG-I signaling in human endocervical epithelial cells modulates inflammatory responses of macrophages and dendritic cells in vitro. PLoS ONE 2014;9(1):e83882
    Sathe A et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB, Flow-IC, ICC/IF
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Kauppila JH et al. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue. J. Oral Pathol. Med. 2014 Oct;
    Kauppila JH et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P, B/N
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Korvala J et al. Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis. J. Oral Pathol. Med. 2014 Aug;43(7):530-7
    Korvala J et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB, IHC-P
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    Yu SL et al. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis. Lupus 2014 Nov;
    Yu SL et al
    2014/01/01
  • 備考:
    Species: Human, Applications: Func, In vitro
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Ruan M et al. Activation of Toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma. PLoS ONE 2014;9(3):e92748
    Ruan M et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Zufferey A et al. Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules. J Proteomics 2014 Apr;101:130-40
    Zufferey A et al
    2014/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Tengroth L et al. Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells. PLoS ONE 2014;9(6):e98239
    Tengroth L et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P, ICC/IF
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Fehri E et al. Expression of Toll-like receptor 9 increases with progression of cervical neoplasia in Tunisian women--a comparative analysis of condyloma, cervical intraepithelial neoplasia and invasive carcinoma. Asian Pac. J. Cancer Prev. 2014;15(15):61
    Fehri E et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 76
  • 文献情報:
    Hamidi S et al. TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts. Biochim. Biophys. Acta 2014 Apr;1841(4):484-94
    Hamidi S et al
    2014/01/01
  • 備考:
    Species: Human, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 77
  • 文献情報:
    Ruan M et al. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma. Int. J. Oncol. 2014 Jun;44(6):2103-10
    Ruan M et al
    2014/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 78
  • 文献情報:
    Veselits M et al. Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes. PLoS ONE 2014;9(3):e89792
    Veselits M et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 79
  • 文献情報:
    Guerrier T et al. TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response. J. Autoimmun. 2014 Jun;51:23-9
    Guerrier T et al
    2014/01/01
  • 備考:
    Species: Human, Applications: In vitro
  • 参照:
    PubMed
  • No.: 80
  • 文献情報:
    Chandel HS et al. Toll-like receptors and CD40 modulate each other&#39;s expression affecting Leishmania major infection. Clin. Exp. Immunol. 2014 May;176(2):283-90
    Chandel HS et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 81
  • 文献情報:
    Huhta H et al. Toll-like receptor 9 expression in the natural history of Barrett mucosa. Virchows Arch. 2015 Jul;467(1):9-18
    Huhta H et al
    2015/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 82
  • 文献情報:
    Tengroth L et al. Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients. PLoS ONE 2014;9(8):e105618
    Tengroth L et al
    2014/01/01
  • 備考:
    Species: Human, Applications: FLOW
  • 参照:
    PubMed
  • No.: 83
  • 文献情報:
    Karlsen M et al. Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sj&#xF6;gren&#39;s syndrome. PLoS ONE 2015;10(3):e0120383
    Karlsen M et al
    2015/01/01
  • 備考:
    Species: Human, Applications: FLOW
  • 参照:
    PubMed
  • No.: 84
  • 文献情報:
    Luckhardt TR et al. TLR9-induced interferon &#x3B2; is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis. Fibrogenesis Tissue Repair 2011;4:18
    Luckhardt TR et al
    2011/01/01
  • 備考:
    Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 85
  • 文献情報:
    Kundu SD et al. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 2008 Feb;68(2):223-9
    Kundu SD et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 86
  • 文献情報:
    Kauppila JH et al. Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology 2011 Oct;59(4):643-9
    Kauppila JH et al
    2011/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 87
  • 文献情報:
    Saito K et al. Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE. Eur. J. Immunol. 2015 Jul;45(7):2028-41
    Saito K et al
    2015/01/01
  • 備考:
    Species: Human, Applications: WB, IP
  • 参照:
    PubMed
  • No.: 88
  • 文献情報:
    V辰is辰nen MR et al. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors. Prostate 2010 Jun;70(8):817-24
    V辰is辰nen MR et al
    2010/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 89
  • 文献情報:
    Ronkainen H et al. Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma. J. Exp. Clin. Cancer Res. 2011;30:84
    Ronkainen H et al
    2011/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 90
  • 文献情報:
    Gantner F et al. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Eur. J. Immunol. 2003 Jun;33(6):1576-85
    Gantner F et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 91
  • 文献情報:
    L坦pez MC et al. Na&#xEF;ve T cells, unconventional NK and NKT cells, and highly responsive monocyte-derived macrophages characterize human cord blood. Immunobiology 2014 Oct;219(10):756-65
    L坦pez MC et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 92
  • 文献情報:
    Dillmann C et al. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-&#x3B1; Production by Human Plasmacytoid Dendritic Cells. J. Immunol. 2016 Feb;196(4):1579-90
    Dillmann C et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 93
  • 文献情報:
    Zhong F et al. Deviation from major codons in the Toll-like receptor genes is associated with low Toll-like receptor expression. Immunology 2005 Jan;114(1):83-93
    Zhong F et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 94
  • 文献情報:
    Jamin A et al. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome. Clin. Exp. Immunol. 2015 Dec;182(3):332-45
    Jamin A et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 95
  • 文献情報:
    Wang H et al. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J. Immunol. 2006 Sep;177(5):2793-802
    Wang H et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 96
  • 文献情報:
    Huggins J et al. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood 2007 Feb;109(4):1611-9
    Huggins J et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 97
  • 文献情報:
    Meseure D et al. Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes. Cancer Microenviron 2016 Jul;
    Meseure D et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 98
  • 文献情報:
    Acharya M et al. &#x3B1;v Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. Nat Commun 2016;7:10917
    Acharya M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 99
  • 文献情報:
    Duhamel M et al. The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways. Sci Rep 2016;6:19360
    Duhamel M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 100
  • 文献情報:
    Ilvesaro JM et al. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion. Mol. Cancer Res. 2008 Oct;6(10):1534-43
    Ilvesaro JM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 101
  • 文献情報:
    Schnerch J et al. Functional TLR9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis. Am. J. Respir. Cell Mol. Biol. 2016 Jul;
    Schnerch J et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 102
  • 文献情報:
    Schneberger D et al. Expression of toll-like receptor 9 in horse lungs. Anat Rec (Hoboken) 2009 Jul;292(7):1068-77
    Schneberger D et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 103
  • 文献情報:
    Mishima Y et al. Decreased Frequency of Intestinal Regulatory CD5+ B Cells in Colonic Inflammation. PLoS ONE 2016;11(1):e0146191
    Mishima Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 104
  • 文献情報:
    Baumann CL et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J. Exp. Med. 2010 Nov;207(12):2689-701
    Baumann CL et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 105
  • 文献情報:
    Siponen M et al. Cathepsin K expression is increased in oral lichen planus. J. Oral Pathol. Med. 2016 May;
    Siponen M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 106
  • 文献情報:
    Lundeen JS et al. Direct measurement of the quantum wavefunction. Nature 2011 Jun;474(7350):188-91
    Lundeen JS et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 107
  • 文献情報:
    Moreira ML et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet. Parasitol. 2016 Apr;220:33-45
    Moreira ML et al
    2016/01/01
  • 備考:
    Species: Canine, Applications: FLOW
  • 参照:
    PubMed
  • No.: 108
  • 文献情報:
    Heftrig D et al. Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients. Mediators Inflamm. 2017;2017:2608349
    Heftrig D et al
    2017/01/01
  • 備考:
    Species: Human, Applications: Flow
  • 参照:
    PubMed
  • No.: 109
  • 文献情報:
    Damiano V et al. Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors. Clin. Cancer Res. 2006 Jan;12(2):577-83
    Damiano V et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 110
  • 文献情報:
    Evangelista MG et al. Early IFN-&#x3B3; production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. Autoimmunity 2016 Jun;49(4):258-67
    Evangelista MG et al
    2016/01/01
  • 備考:
    Species: Mouse, Applications: FLOW
  • 参照:
    PubMed
  • No.: 111
  • 文献情報:
    Yang X et al. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J. Am. Coll. Cardiol. 2009 Feb;53(6):491-500
    Yang X et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 112
  • 文献情報:
    Zambirinis CP et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J. Exp. Med. 2015 Nov;212(12):2077-94
    Zambirinis CP et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: Flow
  • 参照:
    PubMed
  • No.: 113
  • 文献情報:
    Larsson O et al. Substance P represents a novel first-line defense mechanism in the nose. J. Allergy Clin. Immunol. 2018 Jan;141(1):128-136.e3
    Larsson O et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: Flow, ICC/IF, IHC
  • 参照:
    PubMed
  • No.: 114
  • 文献情報:
    Huhta H et al. The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer. J. Histochem. Cytochem. 2016 08;64(8):470-82
    Huhta H et al
    2016/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 115
  • 文献情報:
    Lepp辰nen J et al. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients. Virchows Arch. 2017 Apr;470(4):401-410
    Lepp辰nen J et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 116
  • 文献情報:
    Yang J et al. Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome. Transpl. Immunol. 2018 06;48:39-46
    Yang J et al
    2018/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 117
  • 文献情報:
    Mu L et al. Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression. World Neurosurg 2017 Jan;97:279-283
    Mu L et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 118
  • 文献情報:
    Jeon YK et al. Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination. Oncotarget 2016 Jul;7(27):41811-41824
    Jeon YK et al
    2016/01/01
  • 備考:
    Species: Human, Applications: DB
  • 参照:
    PubMed
  • No.: 119
  • 文献情報:
    Chandler MR et al. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans. PLoS ONE 2017;12(9):e0183832
    Chandler MR et al
    2017/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 120
  • 文献情報:
    Burgue単o JF et al. TLR2 and TLR9 modulate enteric nervous system inflammatory responses to lipopolysaccharide. J Neuroinflammation 2016 08;13(1):187
    Burgue単o JF et al
    2016/01/01
  • 備考:
    Species: Rat, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 121
  • 文献情報:
    Helminen O et al. Localization of nucleic acid-sensing toll-like receptors in human and mouse pancreas. APMIS 2017 Feb;125(2):85-92
    Helminen O et al
    2017/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 122
  • 文献情報:
    Sun Y et al. High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway. Exp. Cell Res. 2017 10;359(2):312-318
    Sun Y et al
    2017/01/01
  • 備考:
    WB
  • 参照:
    PubMed
  • No.: 123
  • 文献情報:
    Lim JS et al. The role of TLR9 in stress-dependent autophagy formation. Biochem. Biophys. Res. Commun. 2016 Dec;481(3-4):219-226
    Lim JS et al
    2016/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 124
  • 文献情報:
    Takahara M et al. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy. Cell Immunol 2019 07;341:103925
    Takahara M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 125
  • 文献情報:
    Natarajan S et al. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468. Immunopharmacol Immunotoxicol 2020 Oct;42(
    Natarajan S et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 126
  • 文献情報:
    Zhou B et al. Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma. Theranostics 2020;10(14):6530-6543
    Zhou B et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 127
  • 文献情報:
    Du XK et al. Necroptosis in pulmonary macrophages mediates lipopolysaccharide-induced lung inflammatory injury by activating ZBP-1. Int Immunopharmacol 2019 Dec;77:105944
    Du XK et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 128
  • 文献情報:
    Korimov叩 A et al. <i>N</i>-Formylated Peptide Induces Increased Expression of Both Formyl Peptide Receptor 2 (Fpr2) and Toll-Like Receptor 9 (TLR9) in Schwannoma Cells-An In Vitro Model for Early Inflammatory Profiling of Schwann Cells. Cells 2020 12;9(12
    Korimov叩 A et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 129
  • 文献情報:
    Nie H et al. Bushen recipe and its disassembled prescriptions inhibit inflammation of liver injury associated with Concanavalin A through Toll&#x2011;like receptor 3/9 signaling pathway. Mol Med Rep 2018 Aug;18(2):1682-1691
    Nie H et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 130
  • 文献情報:
    Wang CY et al. TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity. Biology (Basel) 2020 Oct;9(11)
    Wang CY et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 131
  • 文献情報:
    Richard Albert J et al. Maternal DNMT3A-dependent de novo methylation of the paternal genome inhibits gene expression in the early embryo. Nat Commun 2020 10;11(1):5417
    Richard Albert J et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 132
  • 文献情報:
    Niemczyk G et al. Expression of Toll-Like Receptors in the Animal Model of Bladder Outlet Obstruction. Biomed Res Int 2020;2020:6632359
    Niemczyk G et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 133
  • 文献情報:
    Kuramoto K et al. The autophagy protein Becn1 improves insulin sensitivity by promoting adiponectin secretion via exocyst binding. Cell Rep 2021 May;35(8):109184
    Kuramoto K et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 134
  • 文献情報:
    Li FJ et al. Citrullinated vimentin mediates development and progression of lung fibrosis. Sci Transl Med 2021 03;13(585)
    Li FJ et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 135
  • 文献情報:
    Ishizu T et al. Head and neck squamous cell carcinoma cell lines have an immunomodulatory effect on macrophages independent of hypoxia and toll-like receptor 9. BMC Cancer 2021 Sep;21(1):990
    Ishizu T et al
    2021/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 136
  • 文献情報:
    Branchi V et al. A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer. Diagnostics (Basel) 2021 Sep;11(9)
    Branchi V et al
    2021/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed